$CSWC

BATTIST CHRISTINE purchased $20K of CSWC

BATTIST CHRISTINE purchased 860 shares of CAPITAL SOUTHWEST CORP (CSWC) at $23.23 on 2026-06-17.

Original reporting
SEC EDGAR · BATTIST CHRISTINE
Published Jun 18, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 11:50 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CSWC
Neutral
low confidence
Mentioned
$CSWC
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CSWCNeutralLow
01

Why it matters

An insider open-market purchase was reported, but the disclosure contains no new operational, financial, or strategic information about CSWC.

02

Market read

Traders may note the insider buy, but it is unlikely to materially change valuation expectations without accompanying fundamental news.

03

What to watch

The filing does not include a 10b5-1 plan, but it also does not disclose intent, timing constraints, or whether the purchase follows prior sales, limiting interpretability.

Relevance 4/10Novelty 3/10Timing: filed 2026-06-18 after-hours/late session window

Background

The article is an SEC Form 4 insider transaction disclosure for Capital Southwest Corp (CSWC).

Company-level read

Ticker impact

$CSWCNeutralLow confidence
Context

Capital Southwest Corp director Battist Christine bought 860 shares in an open-market transaction at $23.23 on 2026-06-17, filed 2026-06-18.

Expected impact

Likely minimal immediate price impact; any effect would be sentiment-driven and short-lived.

Evidence & confidence

Form 4 insider purchases can be informative, but the disclosed transaction is small relative to typical market-moving thresholds and provides no new company fundamentals or guidance.

Market effects

None; this is company-specific insider activity with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Insider buys can be driven by diversification, compensation, or routine liquidity needs rather than a bullish view on fundamentals.

Key entities

  • Capital Southwest Corp

    Subject of the Form 4 insider transaction disclosure.

  • Battist Christine

    Director who reported an open-market purchase of 860 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CSWCMed

Capital Southwest stock hits 52-week high at $25.30

Capital Southwest (CSWC) shares hit a 52-week high at $25.30 and last traded near $25.24. The article cites a Q1 fiscal 2027 adjusted EPS of $0.58 vs $0.5647 expected, with revenue of $61.05M vs $61.42M. It also notes an expanded ATM equity offering up to $2B and a Citizens price target raised to $26.00.

$CSWCMed

Capital Southwest (CSWC) Q1 2027 Earnings Call Transcript

Capital Southwest Corporation (CSWC) reported Q1 FY2027 pretax net investment income of $0.57 per share and total investment income of $61 million. It declared a $0.58 regular dividend plus a $0.06 supplemental dividend for a $0.64 total. Credit portfolio grew to $2 billion, new commitments were $222 million, and NAV per share fell to $16.61.

$CSWCMed

Capital Southwest Q1 Earnings Call Highlights

Capital Southwest (NASDAQ: CSWC) reported Q1 call highlights. Its on-balance-sheet credit portfolio rose to $2.0 billion, up 24% from $1.6 billion in June 2025, with 99% first-lien senior secured. Weighted-average debt yield increased to 10.9%. NAV per share fell to $16.61. The company raised $64 million via ATM at $23.47 and discussed potential $250-$300 million originations.

$CSWCLow

CAPITAL SOUTHWEST CORP (CSWC): Results of Operations and Financial Condition

CAPITAL SOUTHWEST CORP (CSWC) filed an SEC Form 8-K — Results of Operations and Financial Condition. cswc-20260716 0000017313 FALSE 0000017313 2026-07-16 2026-07-16 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):